A New Wave. What's the Future of Calcium Modification with Shockwave IVL Now in the U.S.?

Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational... Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis. Read more Show less

Works at Morristown Medical Center, Morristown, NJ, USA. Features in 5 videos on Wondr Medical.... Works at Morristown Medical Center, Morristown, NJ, USA. Features in 5 videos on Wondr Medical. Philippe Genereux generally speaks on Shockwave Lithotripsy (Coronary), Coronary Optical Coherence Tomography (OCT), Stable Coronary Artery Disease (CAD), and Calcified Lesions. Read more Show less

Dr. Riley is an Interventional Cardiologist specializing in the care of patients with complex and... Dr. Riley is an Interventional Cardiologist specializing in the care of patients with complex and high-risk coronary artery disease and cardiogenic shock. He focuses on the treatment of coronary chronic total occlusions, multivessel coronary artery disease (including patients turned down for CABG surgery), atherectomy, and those in need of mechanical circulatory support. He was born in Knoxville, TN and completed his undergraduate education at Furman University with a degree in Chemistry. He attended medical school at the University of Virginia and completed residency in Internal Medicine at the University of Washington. He then completed his Cardiology fellowship at Wake Forest University, during which he obtained a Masters degree in Clinical and Population Translational Science. He then returned to the University of Washington to complete his Interventional Cardiology fellowship, followed by the first ever advanced fellowship in Complex, High-Risk, and Indicated PCI and Hemodynamic Support before joining the group at Christ Hospital. He is very active in clinical research, co-edits a monthly newsletter on high-risk PCI, and enjoys speaking at national and international meetings. Read more Show less

Robert W. Yeh, MD MSc is Associate Chief of Interventional Cardiology at the Beth Israel... Robert W. Yeh, MD MSc is Associate Chief of Interventional Cardiology at the Beth Israel Deaconess Medical Center and the Katz-Silver Associate Professor of Medicine at Harvard Medical School. He is an expert in complex coronary intervention, including chronic total occlusion PCI. He is also the founding Director the Smith Center for Outcomes Research at BIDMC. Read more Show less

Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The... Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial. Read more Show less